Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Heart Valves01:16

Heart Valves

14.7K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
14.7K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

1.3K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

468
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
468
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.3K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.3K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

913
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
913
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

552
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
552

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Adiposity measures predict olfactory processing speed in older adult carriers of the apolipoprotein E ε4 allele.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2011
Same author

Evolution of sensory complexity recorded in a myxobacterial genome.

Proceedings of the National Academy of Sciences of the United States of America·2006
Same author

Induction of surface antigen CD69 expression in T-lymphocytes following exposure to actinomycin D.

International journal of immunopharmacology·2003
Same author

Chemotherapeutic stress mediated by certain antitumor antibiotics induces an atypical CD69+ surface phenotype in peripheral T-lymphocytes.

International immunopharmacology·2002
Same author

Midterm survival of stented versus stentless valves: does concomitant coronary artery bypass grafting impact survival?

Seminars in thoracic and cardiovascular surgery·2002
Same author

Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58.

Science (New York, N.Y.)·2001

Video Experimental Relacionado

Updated: Apr 3, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K

Experiencia temprana con válvulas sin stent versus válvulas con stent.

G Cohen1, G T Christakis, K J Buth

  • 1Division of Cardiovascular Surgery, Sunnybrook Health Sciences Centre and The Toronto Hospital, University of Toronto, Ontario, Canada.

Circulation
|December 31, 1997
PubMed
Resumen

La válvula porcina sin stent (SPV) de Toronto mostró una mejora de la función ventricular después del reemplazo de la válvula aórtica en comparación con las válvulas con stent (STD). Sin embargo, no se observaron diferencias hemodinámicas significativas entre los grupos de VSP y ETS en este estudio.

Más Videos Relacionados

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K

Videos de Experimentos Relacionados

Last Updated: Apr 3, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K

Área de la Ciencia:

  • Cirugía cardiovascular La cirugía cardiovascular es una cirugía cardiovascular.
  • Ciencia de los Biomateriales Ciencia de los Biomateriales.
  • Dispositivos Médicos Dispositivos Médicos para el Cuerpo

Sus antecedentes:

  • La válvula porcina sin stent de Toronto (SPV) se desarrolló para mejorar la hemodinámica en el reemplazo de la válvula aórtica (AVR) al aumentar el área de flujo en comparación con las válvulas con stent tradicionales (STD).
  • La evaluación del rendimiento hemodinámico es crucial para optimizar los resultados después de AVR.

Objetivo del estudio:

  • Para comparar prospectivamente el rendimiento hemodinámico y la remodelación ventricular entre la válvula porcina sin stent de Toronto (SPV) y las válvulas con stent (STD) después del reemplazo aislado de la válvula aórtica.
  • Evaluar las posibles mejoras funcionales en la mecánica ventricular asociadas con la implantación de VSP.

Principales métodos:

  • Un estudio prospectivo en el que participaron 59 pacientes sometidos a AVR aislado (+/- injerto de derivación de la arteria coronaria).
  • Los pacientes recibieron una válvula con stent (STD, n=23) o la válvula porcina sin stent de Toronto (SPV, n=36).
  • Se utilizaron ecocardiografías preoperatorias y postoperatorias de 3 a 6 meses para evaluar los parámetros hemodinámicos y el índice de masa del ventrículo izquierdo.

Principales resultados:

  • Los implantes de SPV eran más grandes en promedio (26,6 mm frente a 24,0 mm, P = 0,0002).
  • El área del orificio efectivo postoperatorio aumentó significativamente (P = 0.0001), especialmente en el grupo SPV (1.9 cm2 frente a 1.5 cm2, P = 0.01).
  • La función ventricular, medida por el acortamiento fraccionario y la velocidad de acortamiento circunferencial, mejoró significativamente en pacientes con VSP (P=0.0004 y P=0.0001, respectivamente).

Conclusiones:

  • Si bien la implantación de SPV se asoció con una mejora de la función ventricular, no se detectaron diferencias hemodinámicas significativas entre los grupos de SPV y ETS.
  • El diseño no aleatorizado puede introducir sesgo de selección, influyendo potencialmente en los resultados observados.
  • Se justifica una investigación adicional a través de un ensayo prospectivo y aleatorizado para determinar definitivamente cualquier ventaja hemodinámica del SPV.